Cite this: Parkinson's Cell Transplant Shows Good Reinnervation at 24 Years - Medscape - May 10, 2016. Authors and Disclosures. Authors and Disclosures Journalist Sue Hughes.

Parkinson’s has seemed like a good candidate for stem cell-derived therapies because people with the disorder have lost cells in the brain, or neurons, that produce the neurotransmitter dopamine.

Dopaminergic cell transplantation may provide new hope for Parkinson's sufferers--if a suitable long-term source of transplantable dopaminergic neurons can be found.

Patients suffering from Parkinson's disease may soon benefit from a powerful treatment option: stem-cell transplants. In a pair of small studies designed primarily to test safety, two teams of ...

A new stem cell therapy for Parkinson’s disease, in which the donor would also become the transplant recipient, is one step closer to human trials after scientists were able to successfully grow ...

Parkinson's disease (PD) ... In their study, rats received a stem cell-derived transplant to replace lost dopaminergic neurons and some of the rats were given free access to a running wheel.

LJI scientists have discovered that T cells may help detect Parkinson's disease years before motor symptoms appear. Your T ...

Parkinson’s is the world’s second most common neurodegenerative disease, with up to 90,000 new cases a year in the US. ... Although a “first proof-of-concept for cell transplantation therapy,” the ...

Parkinson's disease could be the perfect target for stem cell therapy. The etiology of this progressively debilitating disease is clear: scientists know what cells are affected, where those cells ...

S.BIOMEDICS reported that TED-A9, an investigational cell therapy for Parkinson's disease, showed positive data during the Phase 1/2a trial.

Scientists have discovered a groundbreaking potential treatment for Parkinson's disease from a very unlikely source: a stool transplant. Parkinson's is a neurodegenerative disorder that affects ...